Financials data is unavailable for this security.
View more
Year on year Shandong Bailong Chuangyuan Bio-Tech Co Ltd grew revenues 20.28% from 721.89m to 868.26m while net income improved 27.98% from 150.80m to 193.00m.
Gross margin | 31.91% |
---|---|
Net profit margin | 22.44% |
Operating margin | 25.39% |
Return on assets | 12.65% |
---|---|
Return on equity | 14.89% |
Return on investment | 14.84% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Shandong Bailong Chuangyuan Bio-Tech Co Ltd fell by 63.20m. However, the company earned 194.63m from its operations for a Cash Flow Margin of 22.42%. In addition the company used 223.72m on investing activities and also paid 34.12m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.85 |
---|---|
Tangible book value per share | 4.80 |
More ▼
Balance sheet in CNYView more
Current ratio | 2.66 |
---|---|
Quick ratio | 2.22 |
Total debt/total equity | 0.0837 |
---|---|
Total debt/total capital | 0.0773 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 97.64% and 27.98%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | 0.37% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 31.31% |
EPS growth(5 years) | 17.23 |
---|---|
EPS (TTM) vs TTM 1 year ago | 35.70 |
More ▼